Neurociencia del consumo y dependencia de sustancias psicoactivas

More documents

Recommendations

Info

6. TRASTORNOS CONCURRENTESMansvelder HD, McGehee DS (2000) Long-term potentiation of excitatoryinputs to brain reward areas by nicotine. Neuron, 27:349–357.Marder SR, Wirshing WC, Van Putten T (1991) Drug treatment of schizophrenia:overview of recent research. Schizophrenia Research, 4:81–90.Markou A, Kosten TR, Koob GF (1998) Neurobiological similarities in depressionand drug dependence: a self-medication hypothesis. Neuropsychopharmacology,18:135–174.Markou A y colab. (1993) Animal models of drug craving. Psychopharmacology,112:163–182.Marshall DL, Redfern PH, Wonnacott S (1997) Presynaptic nicotinic modulationof dopamine release in the three ascending pathways studied by in vivomicrodialysis: comparison of naïve and chronic nicotine-treated rats. Journal ofNeurochemistry, 68:1511–1519.Mason BJ y colab. (1996) A double-blind, placebo-controlled trial ofdesipramine for primary alcohol dependence stratified on the presence orabsence of major depression. Journal of the American Medical Association,275:761–767.Masterson E, O’Shea B (1984) Smoking and malignancy in schizophrenia.British Journal of Psychiatry, 145:429–432.Mauskopf JA y colab. (1999) Annual health outcomes and treatment costs forschizophrenia populations. Journal of Clinical Psychiatry, 60 Suppl: S14–S19.Meltzer HY (1999) Outcome in schizophrenia: beyond symptom reduction.Journal of Clinical Psychiatry, 60 Suppl: S3–S7.Meltzer HY, Park S, Kessler R (1999) Cognition, schizophrenia, and the atypicalantipsychotic drugs. Proceedings of the National Academy of Sciences of theUnited States of America, 96:13 591–13 593.Menza MA y colab. (1991) Smoking and movement disorders in psychiatricpatients. Biological Psychiatry, 30:109–115.Merlo Pich E y colab. (1995) Increase of extracellular corticotropin-releasing factor-likeimmunoreactivity levels in the amygdala of awake rats during restraintstress and ethanol withdrawal as measured by microdialysis. Journal ofNeuroscience, 15:5439–5447.Miller HL y colab. (1996a) Clinical and biochemical effects of catecholaminedepletion on antidepressant-induced remission of depression. Archives of GeneralPsychiatry, 53:117–128.Miller NS y colab. (1996b) Prevalence of depression and alcohol and other drugdependence in addictions treatment populations. Journal of Psychoactive Drugs,28:111–124.Mittleman G, Bratt AM, Chase R (1998) Heterogeneity of the hippocampus:effects of subfield lesions on locomotion elicited by dopaminergic agonists.Behavioural Brain Research, 92:31–45.Mogenson GJ, Jones DL, Yim CY (1980) From motivation to action: functionalinterface between the limbic system and the motor system. Progress inNeurobiology, 14:69–97.201
NEUROCIENCIA DEL CONSUMO Y DEPENDENCIA DE SUSTANCIAS PSICOACTIVASMoller HJ (1998) Novel antipsychotics and negative symptoms. InternationalClinical Psychopharmacology, 13 Suppl: S43–S47.Mueser KT y colab. (1990) Prevalence of substance abuse in schizophrenia:demographic and clinical correlates. Schizophrenia Bulletin, 16:31–56.Myers JK y colab. (1984) Six-month prevalence of psychiatric disorders in threecommunities, 1980 to 1982. Archives of General Psychiatry, 41:959–967.Nemeroff CB y colab. (1984) Elevated concentrations of CSF corticotropinreleasingfactor-like immunoreactivity in depressed patients. Science,226:1342–1344.Nemeroff CB y colab. (1988) Reduced corticotropin-releasing factor bindingsites in the frontal cortex of suicide victims. Archives of General Psychiatry,45:577–579.Nestler EJ y colab. (2002) Neurobiology of depression. Neuron, 34:13–25.Newcomer JW y colab. (1999) Ketamine-induced NMDA receptor hypofunctionas a model of memory impairment and psychosis. Neuropsychopharmacology,20:106–118.Nomikos GG y colab. (1991) Electroconvulsive shock produces large increasesin the interstitial concentrations of dopamine in the rat striatum: an in vivomicrodialysis study. Neuropsychopharmacology, 4:65–69.Nomikos GG y colab. (1994) Systemic administration of amperozide, a newatypical antipsychotic drug, preferentially increases dopamine release in the ratmedial prefrontal cortex. Psychopharmacology, 115:147–156.Nunes EV y colab. (1993) Imipramine treatment of alcoholism with comorbiddepression. American Journal of Psychiatry, 150:963–965.Nunes EV y colab. (1995) Imipramine treatment of cocaine abuse: possibleboundaries of efficacy. Drug and Alcohol Dependence, 39:185–195.Olincy A, Young DA, Freedman R (1997) Increased levels of the nicotinemetabolite cotinine in schizophrenic smokers compared to other smokers.Biological Psychiatry, 42:1–5.Pallanti S, Quercioli L, Pazzagli A (1999) Effects of clozapine on awareness of illnessand cognition in schizophrenia. Psychiatry Research, 86:239– 249.Parrott AC (1993) Cigarette smoking: effects upon self-rated stress and arousalover the day. Addictive Behaviors, 18:389–395.Parsons LH, Smith AD, Justice JB Jr (1991) Basal extracellular dopamine isdecreased in the rat nucleus accumbens during abstinence from chronic cocaine.Synapse, 9:60–65.Parsons LH, Koob GF, Weiss F (1995) Serotonin dysfunction in the nucleus accumbensof rats during withdrawal after unlimited access to intravenous cocaine.Journal of Pharmacology and Experimental Therapeutics, 274:1182–1191.Patkar AA y colab. (1999) Changing patterns of illicit substance use amongschizophrenic patients: 1984–1996. American Journal on Addictions, 8:65–71.Peroutka SJ, Snyder SH (1980) Long-term antidepressant treatment decreasesspiroperidol-labelled serotonin receptor binding. Science, 210:88–90.202
Page 1:
Neurociencia del consumoy dependenc
Page 4 and 5:
ÍndiceÍndicePrólogoAgradecimient
Page 6 and 7:
ÍNDICESedantes e hipnóticos 73Int
Page 8 and 9:
ÍNDICEFenotipo 148Comorbilidad 148
Page 10 and 11:
PrólogoEl uso y dependencia de sus
Page 12:
AgradecimientosLa Organización Mun
Page 22 and 23:
Capítulo 1IntroducciónEl presente
Page 25 and 26:
NEUROCIENCIA DEL CONSUMO Y DEPENDEN
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 42 and 43:
2. MECANISMOS CEREBRALES: NEUROBIOL
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 88 and 89:
Capítulo 4Psicofarmacología de la
Page 90 and 91:
4. PSICOFARMACOLOGÍA DE LA DEPENDE
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Capítulo 5Bases Genéticas de lasF
Page 148 and 149:
5. BASES GENÉTICAS DE LAS FARMACOD
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173: 5. BASES GENÉTICAS DE LAS FARMACOD
Page 190 and 191: Capítulo 6Trastornos ConcurrentesI
Page 192 and 193: 6. TRASTORNOS CONCURRENTES3. El uso
Page 194 and 195: 6. TRASTORNOS CONCURRENTESy Meador-
Page 196 and 197: 6. TRASTORNOS CONCURRENTESprobablem
Page 198 and 199: 6. TRASTORNOS CONCURRENTESde drogas
Page 200 and 201: 6. TRASTORNOS CONCURRENTESy Turski,
Page 202 and 203: 6. TRASTORNOS CONCURRENTESEl víncu
Page 204 and 205: 6. TRASTORNOS CONCURRENTESAlcohol y
Page 206 and 207: 6. TRASTORNOS CONCURRENTESSerotonin
Page 208 and 209: 6. TRASTORNOS CONCURRENTESFunción
Page 210 and 211: 6. TRASTORNOS CONCURRENTESRECUADRO
Page 212 and 213: 6. TRASTORNOS CONCURRENTEStos psiqu
Page 214 and 215: 6. TRASTORNOS CONCURRENTESCarol G y
Page 216 and 217: 6. TRASTORNOS CONCURRENTESdepressio
Page 218 and 219: 6. TRASTORNOS CONCURRENTESHall RG y
Page 220 and 221: 6. TRASTORNOS CONCURRENTESKapur S,
Page 224 and 225: 6. TRASTORNOS CONCURRENTESPetty F (
Page 226 and 227: 6. TRASTORNOS CONCURRENTESSevy S y
Page 228: 6. TRASTORNOS CONCURRENTESlesions o
Page 231 and 232: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
Page 272 and 273:
Índice AnalíticoNota: los número
Page 274 and 275:
ÍNDICE ANALÍTICOAtropina 103ATV,
Page 276 and 277:
ÍNDICE ANALÍTICOpolíticas de sal
Page 278 and 279:
ÍNDICE ANALÍTICOuso de tabaco 171
Page 280 and 281:
ÍNDICE ANALÍTICOInmunoterapias pa
Page 282 and 283:
ÍNDICE ANALÍTICOParkinson, efecto
Page 284 and 285:
ÍNDICE ANALÍTICOSolventes voláti
Page 286:
Neurociencia del consumo y dependen
show all

Neurociencia del consumo y dependencia de sustancias psicoactivas

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?